Sitagliptin Trial For Safety And Efficacy In Elderly Patients With Moderately Controlled Type 2 Diabetes
Not Applicable
- Conditions
- Type 2 Diabetes
- Registration Number
- JPRN-UMIN000010376
- Lead Sponsor
- STREAM research group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with type 1 diabetes (2) Patients under treatment with insulin (3) Patients under treatment with GLP-1 injection, a DPP4 inhibitor, or an investigational drug (4) Patients with severe renal dysfunction (eGFR: <30 mL/min), including those under treatment with dialysis (5) Patients judged to be ineligible by a physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in the HbA1c level and safety at 3, 6, and 12 months after study initiation
- Secondary Outcome Measures
Name Time Method Blood glucose level at 3, 6, and 12 months after study initiation, Glycated albumin,Proinsulin/insulin ratio,Body weight, Course of diabetic complications, Hematology, Immunological test,